Mohamed Zaki serves as Executive at ADC Therapeutics SA, where they oversee executive responsibilities. Since joining the company, Mohamed Zaki has executed 1 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Dec 6, 2025 involved selling 41,068 shares valued at $135.1K.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| Dec 6, 2025 | ADCT | $135.1K | Payment | 41,068 | $3.29 | Discretionary |
Mohamed Zaki currently holds 421,820 shares of ADC Therapeutics SA (ADCT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Mohamed Zaki has been a net neutral trader of ADCT stock. They have purchased $0 and sold $0 worth of shares.
Mohamed Zaki's most recent insider trade was on Dec 6, 2025, when they sold 41,068 shares at $3.29 per share.
Get notified when new Form 4 filings are submitted